COHERENT CORP.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
COHR$214.66-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows –
Condensed Consolidated Statements of Cash Flows (Unaudited)
($000)
| Nine Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash Flows from Operating Activities | ||
| Net earnings | $550,683 | $128,168 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Depreciation | 170,903 | 188,034 |
| Amortization | 210,423 | 230,741 |
| Share-based compensation expense | 136,049 | 116,649 |
| Non-cash restructuring and impairment charges | 41,464 | 43,002 |
| Amortization of debt issuance costs | 15,138 | 15,661 |
| Loss on disposals of property, plant & equipment | 925 | 112 |
| Unrealized losses (gains) on foreign currency remeasurements and transactions | (10,218) | 6,841 |
| Earnings from equity investments | (294) | (626) |
| Deferred income taxes | (138,035) | (88,101) |
| Gain on sale of business | (124,133) | — |
| Gain on sale of equity investment | (35,632) | — |
| Loss on debt extinguishment | 3,056 | — |
| Increase (decrease) in cash from changes in (net of effects of acquisitions): | ||
| Accounts receivable | (225,268) | (166,115) |
| Inventories | (699,420) | (97,301) |
| Accounts payable | 349,666 | 128,263 |
| Contract liabilities | (2,838) | 4,619 |
| Income taxes | (21,095) | (2,174) |
| Accrued compensation and benefits | 17,930 | 29,874 |
| Other operating net assets (liabilities) | (229,246) | (34,331) |
| Net cash provided by operating activities | 10,058 | 503,316 |
| Cash Flows from Investing Activities | ||
| Additions to property, plant & equipment | (547,228) | (309,486) |
| Proceeds from sale of equity investment | 48,827 | — |
| Proceeds from the sale of business, net of fees | 437,286 | 27,000 |
| Purchases of short-term investments | (825,000) | — |
| Other investing activities | (5,019) | (1,038) |
| Net cash used in investing activities | (891,134) | (283,524) |
| Cash Flows from Financing Activities | ||
| Proceeds from borrowings of Term A Facility | 1,250,000 | — |
| Proceeds from borrowings of Term B Facility | 3,267 | — |
| Proceeds from borrowings of revolving credit facilities | 628,811 | 35,862 |
| Proceeds from issuance of common shares | 2,000,000 | — |
| Payments on existing debt | (1,761,740) | (386,006) |
| Payments on borrowings under revolving credit facilities | (624,852) | (34,148) |
| Debt issuance costs | (9,101) | — |
| Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan | 51,782 | 47,462 |
| Payments in satisfaction of employees’ minimum tax obligations | (51,580) | (48,939) |
| Cash dividends paid | (11,438) | — |
| Other financing activities | 765 | (719) |
| Net cash provided by (used in) financing activities | 1,475,914 | (386,488) |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | (1,973) | 3,040 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 592,865 | (163,656) |
| Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 1,632,913 | 1,789,686 |
| Cash, Cash Equivalents, and Restricted Cash at End of Period | $2,225,778 | $1,626,030 |
| Supplemental Information | ||
| Cash paid for interest | $135,372 | $187,799 |
|---|---|---|
| Cash paid for income taxes | $167,849 | $107,784 |
| Non-Cash Investing and Financing Activities: | ||
| Additions to property, plant & equipment included in accounts payable | $201,935 | $77,751 |
| Conversion of Series B preferred stock to common stock | $2,506,885 | $— |
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets that sum to the total of the same amounts shown in the Condensed Consolidated Statements of Cash Flows.
| March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash and cash equivalents | $1,592,730 | $890,258 |
| Restricted cash, current | 42,033 | 19,064 |
| Restricted cash, non-current | 591,015 | 716,708 |
| Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows | $2,225,778 | $1,626,030 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.